Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients
- 1 November 2005
- journal article
- research article
- Published by Elsevier BV in Kidney International
- Vol. 68 (5), 2298-2303
- https://doi.org/10.1111/j.1523-1755.2005.00689.x
Abstract
Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients.Keywords
This publication has 11 references indexed in Scilit:
- Safety and immunogenicity profile of an experimental hepatitis B vaccine adjuvanted with AS04Vaccine, 2004
- The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder populationVaccine, 2002
- Immune response of HLA DQ2 positive subjects, vaccinated with HBsAg/AS04, a hepatitis B vaccine with a novel adjuvantVaccine, 2002
- Persistence of immunologic memory for 13 years in recipients of a recombinant hepatitis B vaccineVaccine, 2001
- A prophylactic hepatitis B vaccine with a novel adjuvant systemVaccine, 2001
- Factors influencing response to hepatitis B virus vaccination in hemodialysis patientsTransplantation Proceedings, 2000
- Intracutaneous versus intramuscular hepatitis B vaccination in primary non-responding haemodialysis patientsNephrology Dialysis Transplantation, 1996
- Effects of different dose levels and vaccination schedules on immune response to a recombinant DNA hepatitis B vaccine in haemodialysis patientsVaccine, 1990
- Hepatitis B Virus Transmission Associated with a Multiple-Dose Vial in a Hemodialysis UnitAnnals of Internal Medicine, 1983
- Host responses to hepatitis B infection in patients in a chronic hemodialysis unitKidney International, 1977